Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02853448 · ClinicalTrials.gov registry record · NA
Evaluation of a Device That Separates Blood Cells From Serum/Plasma
A NA study, sponsored by Boston University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02853448 is a NA study that has completed, run by Boston University. The registered enrollment target is 18 participants.
The verdict
NCT02853448, a NA study, has completed, sponsored by Boston University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
There are many instances where there is no access to a centrifuge (Emergency wards, EMT truck, battle field, etc.) or when a result is needed immediately (myocardial infarction); a new collection tube which could separate serum and plasma from whole blood immediately upon, if not during, collection, would be extremely beneficial. Such a new tube could save time and cost by eliminating centrifugation steps that are currently required to obtain serum and plasma.
Interventions
- DEVICE Novel Blood Drawing Apparatus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2016-01 |
| Est. Completion | 2022-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02853448
The ClinicalTrials.gov registry entry for NCT02853448 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel Blood Drawing Apparatus is the first listed.
NCT02853448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02853448 about?
NCT02853448 is a clinical study titled "Evaluation of a Device That Separates Blood Cells From Serum/Plasma". There are many instances where there is no access to a centrifuge (Emergency wards, EMT truck, battle field, etc.) or when a result is needed immediately (myocardial infarction); a new collection tube which could separate serum and plasma from whole blood immediately upon, if not during, collection,...
What is the current status of trial NCT02853448?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2016-01. Estimated completion is 2022-06-20.
What interventions are being tested in trial NCT02853448?
The interventions under investigation include: Novel Blood Drawing Apparatus (DEVICE).
Who is sponsoring clinical trial NCT02853448?
This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.